Global Compounding Pharmacies Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The Global Compounding Pharmacies market is anticipated to rise at a value CAGR of 6.1% over 20202028. According to a study published by Insure Insights on the Global Compounding Pharmacy Market. Compounding refers to the process of combining, mixing, or altering ingredients to create a medication as per the needs of an individual patient. Compounding comprises the combining of two or more drugs and then dispensing them to the patient. Compound pharmacies are more actively functioning in hospital pharmacies. The rise in the geriatric population has generated a lucrative market growth owing to the demand for anti-aging compounded drugs.
Technological developments in compounding medications have driven the market.
The benefits associated with compounding medications and innovative techniques and technological advancements in compounding pharmacies have primarily driven the market. An increase in the number of incidents where patients do not respond to traditional treatments and the need to customize medicines according to a patients necessity has increased the demand for compounding pharmacies. Compounding pharmacies have made the making of medication easier to use; medicines are allergy-friendly; these factors have augmented market growth. An increase in the number of dispensed prescriptions around the globe is further surging demand in the market.
The oral medication segment grew the most in the Global Compounding Pharmacies market.
Based on product, the oral medications segment grew the most because they are the most convenient dosage form and are most preferred by patients. Moreover, oral medication is economical and is relatively cheaper than other forms of medication. The oral route is non-invasive, and the administration of oral route medications does not require trained personnel. Tablets are the most preferred form of oral medication. These factors have increased the demand for oral medication.
In terms of therapeutic use, the hormone replacement segment has augmented the segmental growth. The hormonal imbalance, especially in women, has mounted the segmental market. It is essential to balance the estrogen and progesterone levels during menopause. Based on the distribution channels, hospital pharmaceutics has held the most remarkable growth due to the rise in the admission of patients to hospitals.
The Global Compounding Pharmacies Market will be dominated by North America.
Compounding acceptance for medication together with favorable reimbursement policies has fostered regional growth. The technological advancements for effective compounding of medications and well-established healthcare facilities in North America are attributed to the surge in the growth of the market. The rise in the number of compounding pharmacies and an increase in research and development activities have propelled the growth of the compounding pharmacy market. The increase in the prevalence of chronic disorders and the upsurge in the geriatric population has proved to be lucrative for the regional market.
The competitors main strategies are strategic collaboration, mergers, and acquisitions.
The players in the global compounding pharmacy market are fragmented. Collaborations, mergers, and acquisitions are strategies used by competitors. The key competitors in the Global Compounding Pharmacies Market are B. Braun, Doughertys Pharmacy, Institutional Pharmacy Solutions, Fresenius Kabi, Lorraines Pharmacy, Clinigen Group, McGuff Company, Fagron, AmerisourceBergen, and Rx3 Pharmacy.
B. Braun: B.Braun is one of the key competitors in the Global Compounding Pharmacies Market. In July 2019, B.Braun announced the acquisition of the business operations of Nephtec GmbH. The acquisition was made by B. Braun to strengthen its product portfolio in the area of the central preparation of dialysis concentrates.
Fagron is a well-known competitor in the global compounding pharmacy market. In April 2018, Fagron announced the acquisition of Humco; together they are a developer, manufacturer, and supplier of patented delivery vehicles and branded pharmaceutical products. The deal was for USD 47.5 million. The acquisition was made by Fagron to strengthen its strategic position in the USA.
Scope of the Report
By Product
Oral
Topical
Others
By Therapeutic Use
Hormone Replacement
Pain Management
Dermatology applications
Specialty drugs
By Distribution Channel
Hospital pharmacy
Others
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Technological developments in compounding medications have driven the market.
The benefits associated with compounding medications and innovative techniques and technological advancements in compounding pharmacies have primarily driven the market. An increase in the number of incidents where patients do not respond to traditional treatments and the need to customize medicines according to a patients necessity has increased the demand for compounding pharmacies. Compounding pharmacies have made the making of medication easier to use; medicines are allergy-friendly; these factors have augmented market growth. An increase in the number of dispensed prescriptions around the globe is further surging demand in the market.
The oral medication segment grew the most in the Global Compounding Pharmacies market.
Based on product, the oral medications segment grew the most because they are the most convenient dosage form and are most preferred by patients. Moreover, oral medication is economical and is relatively cheaper than other forms of medication. The oral route is non-invasive, and the administration of oral route medications does not require trained personnel. Tablets are the most preferred form of oral medication. These factors have increased the demand for oral medication.
In terms of therapeutic use, the hormone replacement segment has augmented the segmental growth. The hormonal imbalance, especially in women, has mounted the segmental market. It is essential to balance the estrogen and progesterone levels during menopause. Based on the distribution channels, hospital pharmaceutics has held the most remarkable growth due to the rise in the admission of patients to hospitals.
The Global Compounding Pharmacies Market will be dominated by North America.
Compounding acceptance for medication together with favorable reimbursement policies has fostered regional growth. The technological advancements for effective compounding of medications and well-established healthcare facilities in North America are attributed to the surge in the growth of the market. The rise in the number of compounding pharmacies and an increase in research and development activities have propelled the growth of the compounding pharmacy market. The increase in the prevalence of chronic disorders and the upsurge in the geriatric population has proved to be lucrative for the regional market.
The competitors main strategies are strategic collaboration, mergers, and acquisitions.
The players in the global compounding pharmacy market are fragmented. Collaborations, mergers, and acquisitions are strategies used by competitors. The key competitors in the Global Compounding Pharmacies Market are B. Braun, Doughertys Pharmacy, Institutional Pharmacy Solutions, Fresenius Kabi, Lorraines Pharmacy, Clinigen Group, McGuff Company, Fagron, AmerisourceBergen, and Rx3 Pharmacy.
B. Braun: B.Braun is one of the key competitors in the Global Compounding Pharmacies Market. In July 2019, B.Braun announced the acquisition of the business operations of Nephtec GmbH. The acquisition was made by B. Braun to strengthen its product portfolio in the area of the central preparation of dialysis concentrates.
Fagron is a well-known competitor in the global compounding pharmacy market. In April 2018, Fagron announced the acquisition of Humco; together they are a developer, manufacturer, and supplier of patented delivery vehicles and branded pharmaceutical products. The deal was for USD 47.5 million. The acquisition was made by Fagron to strengthen its strategic position in the USA.
Scope of the Report
By Product
Oral
Topical
Others
By Therapeutic Use
Hormone Replacement
Pain Management
Dermatology applications
Specialty drugs
By Distribution Channel
Hospital pharmacy
Others
By Region
North America
Europe
Asia Pacific
Rest Of World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Compounding Pharmacies Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Compounding Pharmacies Market -Industry Snapshots
6.1 Overview
6.1.1 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Compounding Pharmacies Market Analysis, by Product
7.1 Overview
7.2 Key Findings for Compounding Pharmacies Market- By Product
7.2.1 Compounding Pharmacies Market Oral
7.2.2 Compounding Pharmacies Market- Topical
7.2.3 Compounding Pharmacies Market- Others
Chapter 8 Global Compounding Pharmacies Market Analysis, by Therapeutic Use
8.1 Overview
8.2 Key Findings for Compounding Pharmacies Market- By Therapeutic Use
8.2.1 Compounding Pharmacies Market- Hormone Replacement
8.2.2 Compounding Pharmacies Market- Pain Management
8.2.3 Compounding Pharmacies Market- Dermatology applications
8.2.4 Compounding Pharmacies Market- Specialty drugs
Chapter 9 Global Compounding Pharmacies Market Analysis, by Distribution Channel
9.1 Overview
9.2 Key Findings for Compounding Pharmacies Market- By Distribution Channel
9.2.1 Compounding Pharmacies Market- Hospital pharmacy
9.2.2 Compounding Pharmacies Market- Others
Chapter 10 Compounding Pharmacies Market Analysis by Region
10.1 Key Findings for Compounding Pharmacies Market- By region
10.2 Overview
10.2.1 Global Compounding Pharmacies Market Analysis, By Product, 2019 - 2028
10.2.2 Global Compounding Pharmacies Market Analysis, By Therapeutic Use, 2019 - 2028
10.2.3 Global Compounding Pharmacies Market Analysis, By Distribution Channel , 2019 - 2028
10.3 Compounding Pharmacies Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Product
10.3.6 North America Market, By Therapeutic Use
10.3.7 North America Market, By Distribution Channel
10.4 Compounding Pharmacies Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Product
10.4.8 Europe Market, By Therapeutic Use
10.4.9 Europe market by, Distribution Channel
10.5 Compounding Pharmacies Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Product
10.5.7 Asia Pacific Market, By Therapeutic Use
10.5.8 Asia Pacific Market, By Distribution Channel
10.6 Compounding Pharmacies Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Product
10.6.6 Latin America, Middle East and Africa Market, By Therapeutic Use
10.6.7 Latin America, Middle East and Africa Market, By Distribution Channel
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments
Chapter 12 Company Profiles- Snapshot
12.1 B. Braun
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Doughertys Pharmacy
12.3 Institutional Pharmacy Solutions
12.4 Fresenius Kabi
12.5 Lorraines Pharmacy
12.6 Clinigen Group
12.7 McGuff Company
12.8 Fagron
12.9 AmerisourceBergen
12.10 Rx3 Pharmacy
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 13 Appendix
TABLE 2 Compounding Pharmacies market by Product 2, 2019 - 2028 (USD Million)
TABLE 3 Compounding Pharmacies market by Product 3, 2019 - 2028 (USD Million)
TABLE 4 Compounding Pharmacies market by Therapeutic Use 1, 2019 - 2028 (USD Million)
TABLE 5 Compounding Pharmacies market by Therapeutic Use 2, 2019 - 2028 (USD Million)
TABLE 6 Compounding Pharmacies market by Therapeutic Use 3, 2019 - 2028 (USD Million)
TABLE 7 Compounding Pharmacies market by Therapeutic Use 4, 2019 - 2028 (USD Million)
TABLE 8 Compounding Pharmacies market by Distribution Channel 1, 2019 - 2028 (USD Million)
TABLE 9 Compounding Pharmacies market by Distribution Channel 2, 2019 - 2028 (USD Million)
TABLE 10 Global Compounding Pharmacies Market Value, By Product, 2019 - 2028 (US$ Bn)
TABLE 11 Global Compounding Pharmacies Market Value, By Therapeutic Use, 2019 - 2028 (US$ Bn)
TABLE 12 Global Compounding Pharmacies Market Value, By Distribution Channel , 2019 - 2028 (US$ Bn)
TABLE 13 Compounding Pharmacies Market Analysis by North America (USD Million), 2019 - 2028
TABLE 14 U.S. Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 15 U.S. Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 16 U.S. Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 17 U.S. Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 18 Canada Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 19 Canada Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 20 Canada Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 21 Canada Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 22 Mexico Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 23 Mexico Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 24 Mexico Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 25 Mexico Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 26 Compounding Pharmacies Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 27 Germany Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 28 Germany Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 29 Germany Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 30 Germany Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 32 United Kingdom Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 33 United Kingdom Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 34 United Kingdom Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 35 France Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 36 France Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 37 France Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 38 France Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 39 Italy Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 40 Italy Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 41 Italy Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 42 Italy Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 43 Rest Of Europe Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 44 Rest Of Europe Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 45 Rest Of Europe Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 46 Rest of Europe Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 47 Compounding Pharmacies Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 48 China Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 49 China Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 50 China Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 51 China Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 52 Japan Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 53 Japan Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 54 Japan Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 55 Japan Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 56 India Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 57 India Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 58 India Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 59 India Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 61 Rest of APAC Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 62 Rest of APAC Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 63 Rest of APAC Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 64 Compounding Pharmacies Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 65 Middle East & Africa (MEA) Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 66 Middle East & Africa (MEA) Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 67 Middle East & Africa (MEA) Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 68 Middle East & Africa (MEA) Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 69 Latin America Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 70 Latin America Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 71 Latin America Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 72 Latin America Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 74 Rest Of World Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 75 Rest Of World Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 76 Rest Of World Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
Chapter 1
FIG. 2 Global Compounding Pharmacies Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Compounding Pharmacies Market Value Contribution, By Product, 2019 & 2026 (%)
FIG. 9 Global Compounding Pharmacies Market Value Contribution, By Therapeutic Use, 2019 & 2026 (%)
FIG. 10 Global Compounding Pharmacies Market Value Contribution, By Distribution Channel , 2019 & 2026 (%)
FIG. 11 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Compounding Pharmacies Market Segment 1 North America
FIG. 14 Compounding Pharmacies Market Segment 2 North America
FIG. 15 Compounding Pharmacies Market Segment 3 North America
FIG. 16 Compounding Pharmacies U.S. outlook, 2019 & 2026
FIG. 17 Compounding Pharmacies Canada outlook, 2019 & 2026
FIG. 18 Compounding Pharmacies Mexico outlook, 2019 & 2026
FIG. 19 Europe Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Compounding Pharmacies Market Segment 1 Europe
FIG. 21 Compounding Pharmacies Market Segment 2 Europe
FIG. 22 Compounding Pharmacies Market Segment 3 Europe
FIG. 23 Compounding Pharmacies Germany outlook, 2019 & 2026
FIG. 24 Compounding Pharmacies United Kingdom outlook, 2019 & 2026
FIG. 25 Compounding Pharmacies France outlook, 2019 & 2026
FIG. 26 Compounding Pharmacies Italy outlook, 2019 & 2026
FIG. 27 Compounding Pharmacies Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Compounding Pharmacies Market Segment 1 Asia Pacific
FIG. 30 Compounding Pharmacies Market Segment 2 Asia Pacific
FIG. 31 Compounding Pharmacies Market Segment 2 Asia Pacific
FIG. 32 Compounding Pharmacies China outlook, 2019 & 2026
FIG. 33 Compounding Pharmacies Japan outlook, 2019 & 2026
FIG. 34 Compounding Pharmacies India outlook, 2019 & 2026
FIG. 35 Compounding Pharmacies Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Compounding Pharmacies Market Segment 1 Rest Of World
FIG. 38 Compounding Pharmacies Market Segment 2 Rest Of World
FIG. 39 Compounding Pharmacies Market Segment 3 Rest Of World
FIG. 40 Compounding Pharmacies Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Compounding Pharmacies Latin America outlook, 2019 & 2026
FIG. 42 Compounding Pharmacies Rest Of World outlook, 2019 & 2026
Companies Mentioned
B. Braun
Doughertys Pharmacy
Institutional Pharmacy Solutions
Fresenius Kabi
Lorraines Pharmacy
Clinigen Group
McGuff Company
Fagron
AmerisourceBergen
Rx3 Pharmacy
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Compounding Pharmacies Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Compounding Pharmacies Market -Industry Snapshots
6.1 Overview
6.1.1 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Compounding Pharmacies Market Analysis, by Product
7.1 Overview
7.2 Key Findings for Compounding Pharmacies Market- By Product
7.2.1 Compounding Pharmacies Market Oral
7.2.2 Compounding Pharmacies Market- Topical
7.2.3 Compounding Pharmacies Market- Others
Chapter 8 Global Compounding Pharmacies Market Analysis, by Therapeutic Use
8.1 Overview
8.2 Key Findings for Compounding Pharmacies Market- By Therapeutic Use
8.2.1 Compounding Pharmacies Market- Hormone Replacement
8.2.2 Compounding Pharmacies Market- Pain Management
8.2.3 Compounding Pharmacies Market- Dermatology applications
8.2.4 Compounding Pharmacies Market- Specialty drugs
Chapter 9 Global Compounding Pharmacies Market Analysis, by Distribution Channel
9.1 Overview
9.2 Key Findings for Compounding Pharmacies Market- By Distribution Channel
9.2.1 Compounding Pharmacies Market- Hospital pharmacy
9.2.2 Compounding Pharmacies Market- Others
Chapter 10 Compounding Pharmacies Market Analysis by Region
10.1 Key Findings for Compounding Pharmacies Market- By region
10.2 Overview
10.2.1 Global Compounding Pharmacies Market Analysis, By Product, 2019 - 2028
10.2.2 Global Compounding Pharmacies Market Analysis, By Therapeutic Use, 2019 - 2028
10.2.3 Global Compounding Pharmacies Market Analysis, By Distribution Channel , 2019 - 2028
10.3 Compounding Pharmacies Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Product
10.3.6 North America Market, By Therapeutic Use
10.3.7 North America Market, By Distribution Channel
10.4 Compounding Pharmacies Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Product
10.4.8 Europe Market, By Therapeutic Use
10.4.9 Europe market by, Distribution Channel
10.5 Compounding Pharmacies Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Product
10.5.7 Asia Pacific Market, By Therapeutic Use
10.5.8 Asia Pacific Market, By Distribution Channel
10.6 Compounding Pharmacies Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Product
10.6.6 Latin America, Middle East and Africa Market, By Therapeutic Use
10.6.7 Latin America, Middle East and Africa Market, By Distribution Channel
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments
Chapter 12 Company Profiles- Snapshot
12.1 B. Braun
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Doughertys Pharmacy
12.3 Institutional Pharmacy Solutions
12.4 Fresenius Kabi
12.5 Lorraines Pharmacy
12.6 Clinigen Group
12.7 McGuff Company
12.8 Fagron
12.9 AmerisourceBergen
12.10 Rx3 Pharmacy
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 13 Appendix
List Of Tables
TABLE 1 Compounding Pharmacies market by Product 1, 2019 - 2028 (USD Million)TABLE 2 Compounding Pharmacies market by Product 2, 2019 - 2028 (USD Million)
TABLE 3 Compounding Pharmacies market by Product 3, 2019 - 2028 (USD Million)
TABLE 4 Compounding Pharmacies market by Therapeutic Use 1, 2019 - 2028 (USD Million)
TABLE 5 Compounding Pharmacies market by Therapeutic Use 2, 2019 - 2028 (USD Million)
TABLE 6 Compounding Pharmacies market by Therapeutic Use 3, 2019 - 2028 (USD Million)
TABLE 7 Compounding Pharmacies market by Therapeutic Use 4, 2019 - 2028 (USD Million)
TABLE 8 Compounding Pharmacies market by Distribution Channel 1, 2019 - 2028 (USD Million)
TABLE 9 Compounding Pharmacies market by Distribution Channel 2, 2019 - 2028 (USD Million)
TABLE 10 Global Compounding Pharmacies Market Value, By Product, 2019 - 2028 (US$ Bn)
TABLE 11 Global Compounding Pharmacies Market Value, By Therapeutic Use, 2019 - 2028 (US$ Bn)
TABLE 12 Global Compounding Pharmacies Market Value, By Distribution Channel , 2019 - 2028 (US$ Bn)
TABLE 13 Compounding Pharmacies Market Analysis by North America (USD Million), 2019 - 2028
TABLE 14 U.S. Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 15 U.S. Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 16 U.S. Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 17 U.S. Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 18 Canada Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 19 Canada Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 20 Canada Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 21 Canada Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 22 Mexico Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 23 Mexico Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 24 Mexico Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 25 Mexico Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 26 Compounding Pharmacies Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 27 Germany Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 28 Germany Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 29 Germany Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 30 Germany Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 32 United Kingdom Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 33 United Kingdom Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 34 United Kingdom Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 35 France Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 36 France Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 37 France Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 38 France Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 39 Italy Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 40 Italy Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 41 Italy Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 42 Italy Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 43 Rest Of Europe Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 44 Rest Of Europe Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 45 Rest Of Europe Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 46 Rest of Europe Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 47 Compounding Pharmacies Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 48 China Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 49 China Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 50 China Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 51 China Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 52 Japan Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 53 Japan Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 54 Japan Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 55 Japan Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 56 India Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 57 India Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 58 India Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 59 India Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 61 Rest of APAC Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 62 Rest of APAC Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 63 Rest of APAC Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 64 Compounding Pharmacies Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 65 Middle East & Africa (MEA) Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 66 Middle East & Africa (MEA) Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 67 Middle East & Africa (MEA) Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 68 Middle East & Africa (MEA) Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 69 Latin America Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 70 Latin America Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 71 Latin America Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 72 Latin America Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Compounding Pharmacies Market, 2019 - 2028 (USD Million)
TABLE 74 Rest Of World Compounding Pharmacies Market, By Product, 2019 - 2028 (USD Million)
TABLE 75 Rest Of World Compounding Pharmacies Market, By Therapeutic Use, 2019 - 2028 (USD Million)
TABLE 76 Rest Of World Compounding Pharmacies Market, By Distribution Channel , 2019 - 2028 (USD Million)
Chapter 1
List Of Figures
FIG. 1 Global Compounding Pharmacies: Market SegmentationFIG. 2 Global Compounding Pharmacies Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Compounding Pharmacies Market Value Contribution, By Product, 2019 & 2026 (%)
FIG. 9 Global Compounding Pharmacies Market Value Contribution, By Therapeutic Use, 2019 & 2026 (%)
FIG. 10 Global Compounding Pharmacies Market Value Contribution, By Distribution Channel , 2019 & 2026 (%)
FIG. 11 Global Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Compounding Pharmacies Market Segment 1 North America
FIG. 14 Compounding Pharmacies Market Segment 2 North America
FIG. 15 Compounding Pharmacies Market Segment 3 North America
FIG. 16 Compounding Pharmacies U.S. outlook, 2019 & 2026
FIG. 17 Compounding Pharmacies Canada outlook, 2019 & 2026
FIG. 18 Compounding Pharmacies Mexico outlook, 2019 & 2026
FIG. 19 Europe Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Compounding Pharmacies Market Segment 1 Europe
FIG. 21 Compounding Pharmacies Market Segment 2 Europe
FIG. 22 Compounding Pharmacies Market Segment 3 Europe
FIG. 23 Compounding Pharmacies Germany outlook, 2019 & 2026
FIG. 24 Compounding Pharmacies United Kingdom outlook, 2019 & 2026
FIG. 25 Compounding Pharmacies France outlook, 2019 & 2026
FIG. 26 Compounding Pharmacies Italy outlook, 2019 & 2026
FIG. 27 Compounding Pharmacies Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Compounding Pharmacies Market Segment 1 Asia Pacific
FIG. 30 Compounding Pharmacies Market Segment 2 Asia Pacific
FIG. 31 Compounding Pharmacies Market Segment 2 Asia Pacific
FIG. 32 Compounding Pharmacies China outlook, 2019 & 2026
FIG. 33 Compounding Pharmacies Japan outlook, 2019 & 2026
FIG. 34 Compounding Pharmacies India outlook, 2019 & 2026
FIG. 35 Compounding Pharmacies Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Compounding Pharmacies Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Compounding Pharmacies Market Segment 1 Rest Of World
FIG. 38 Compounding Pharmacies Market Segment 2 Rest Of World
FIG. 39 Compounding Pharmacies Market Segment 3 Rest Of World
FIG. 40 Compounding Pharmacies Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Compounding Pharmacies Latin America outlook, 2019 & 2026
FIG. 42 Compounding Pharmacies Rest Of World outlook, 2019 & 2026
Companies Mentioned
B. Braun
Doughertys Pharmacy
Institutional Pharmacy Solutions
Fresenius Kabi
Lorraines Pharmacy
Clinigen Group
McGuff Company
Fagron
AmerisourceBergen
Rx3 Pharmacy
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportCOVID-19 Outbreak-Global Compounding Pharmacies Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Pharmacy compounding is the art and science of preparing personalized medications for patients. Compounded medications are made based on a practitioners prescription in which individual ingredients are mixed together in
View ReportCOVID-19 Outbreak-Global Compounding Pharmacy Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Compounding Pharmacy market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally, this
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
